Vitamin D3 Attenuates Delirium-Like Cognitive Impairment in a Postoperative Mouse Model
Abstract
Delirium is an acute neurocognitive impairment triggered by physiological stressors such as medical illness, surgery, or medication use. Although often transient, it is associated with adverse clinical outcomes. Current management primarily relies on nonpharmacological or symptomatic approaches; however, their effectiveness remains limited. Therefore, strategies that target the underlying pathophysiological mechanisms of delirium are of considerable clinical interest. Neuroinflammation has been proposed as a key mechanism in the development of delirium, with inflammatory cytokines produced during systemic inflammation impairing neuronal function. Vitamin D3 (VD3) exerts neuroprotective effects by suppressing the production of inflammatory cytokines. In this study, we hypothesized that VD3 reduces the risk of delirium. To test this hypothesis, a mouse model of postoperative delirium was established using anesthesia and surgery (AS). Cognitive function was assessed using behavioral tests, including the novel object recognition test. Mice subjected to AS exhibited impaired cognitive function, whereas VD3 administration attenuated this impairment. Serum interleukin-6 levels were elevated in the AS group but were reduced following VD3 treatment, consistent with the behavioral findings. These findings suggest that VD3 attenuates cognitive impairment in this postoperative delirium-like mouse model and is associated with reduced serum IL-6 levels. Further studies are required to clarify the underlying mechanisms and the relationship between peripheral and central inflammatory responses.
Related
- Beyond bone health: is vitamin D the next modifiable risk factor for pediatric postoperative delirium?
- Cognitive Trajectories of Post-Stroke Delirium: Longitudinal Global and Domain-Specific Impairment and Digital Markers
- Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management.
- Retrospective evaluation of predictors and clinical impact of postoperative delirium in liver transplant recipients
- Commentary: Incidence and independent risk factors for postoperative delirium in ICU patients after cardiopulmonary bypass cardiac surgery: a retrospective cohort study
BibTeX
@article{nakatomi2026vitamin,
title = {{Vitamin D3 Attenuates Delirium-Like Cognitive Impairment in a Postoperative Mouse Model}},
author = {Kyoka Nakatomi and Koki Okawa and Yuki Shigetsura and Natsuki Imayoshi and Yukiko Miyoshi and Hirotsugu Kawashima and Hiromichi Inaba and Shimpei Yamasaki and Keisuke Umemura and Keiko Ikuta and Yurie Katsube and Daiki Hira and Shunsaku Nakagawa and Masahiro Tsuda and Tomohiro Terada},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = sep,
doi = {10.1248/bpb.b26-00245},
url = {https://www.jstage.jst.go.jp/article/bpb/49/9/49_b26-00245/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Vitamin D3 Attenuates Delirium-Like Cognitive Impairment in a Postoperative Mouse Model
AU - Kyoka Nakatomi
AU - Koki Okawa
AU - Yuki Shigetsura
AU - Natsuki Imayoshi
AU - Yukiko Miyoshi
AU - Hirotsugu Kawashima
AU - Hiromichi Inaba
AU - Shimpei Yamasaki
AU - Keisuke Umemura
AU - Keiko Ikuta
AU - Yurie Katsube
AU - Daiki Hira
AU - Shunsaku Nakagawa
AU - Masahiro Tsuda
AU - Tomohiro Terada
PY - 2026
DA - 2026/09/05
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00245
UR - https://www.jstage.jst.go.jp/article/bpb/49/9/49_b26-00245/_article
AB - Delirium is an acute neurocognitive impairment triggered by physiological stressors such as medical illness, surgery, or medication use. Although often transient, it is associated with adverse clinical outcomes. Current management primarily relies on nonpharmacological or symptomatic approaches; however, their effectiveness remains limited. Therefore, strategies that target the underlying pathophysiological mechanisms of delirium are of considerable clinical interest. Neuroinflammation has been proposed as a key mechanism in the development of delirium, with inflammatory cytokines produced during systemic inflammation impairing neuronal function. Vitamin D3 (VD3) exerts neuroprotective effects by suppressing the production of inflammatory cytokines. In this study, we hypothesized that VD3 reduces the risk of delirium. To test this hypothesis, a mouse model of postoperative delirium was established using anesthesia and surgery (AS). Cognitive function was assessed using behavioral tests, including the novel object recognition test. Mice subjected to AS exhibited impaired cognitive function, whereas VD3 administration attenuated this impairment. Serum interleukin-6 levels were elevated in the AS group but were reduced following VD3 treatment, consistent with the behavioral findings. These findings suggest that VD3 attenuates cognitive impairment in this postoperative delirium-like mouse model and is associated with reduced serum IL-6 levels. Further studies are required to clarify the underlying mechanisms and the relationship between peripheral and central inflammatory responses.
SN - 1347-5215
SN - 0918-6158
ER -